Management of Keloid in Pinna
For keloids on the pinna, surgical excision combined with intralesional triamcinolone acetonide injections (10-40 mg/mL) starting within one week post-operatively and repeated every 2 weeks for 4-6 sessions is the most effective approach, achieving 94-96% success rates.
Primary Treatment Algorithm
First-Line: Combined Surgical and Corticosteroid Approach
The evidence strongly supports a multimodal strategy rather than monotherapy, as surgical excision alone carries recurrence rates exceeding 50% 1, 2.
Surgical Technique:
- Perform extralesional excision (removing the keloid with its core)
- For helical rim keloids >2.5 cm, consider helical rim advancement flap reconstruction to achieve tension-free closure, as wound tension is a critical risk factor for recurrence 3
- The advancement flap technique places tension on the underlying cartilage rather than dermis, explaining its superior outcomes 3
Postoperative Corticosteroid Protocol:
- Begin triamcinolone acetonide injections within one week after suture removal 1, 2
- Use 10-40 mg/mL concentration depending on lesion characteristics 1
- Inject every 2 weeks for 4-6 sessions 2
- This protocol achieved 96.7% success rate (29/30 patients) in recent studies 2
Alternative Combined Approaches
Surgery + Radiation Therapy: If corticosteroid therapy is contraindicated or patient preference favors radiation:
- Postoperative superficial radiation therapy (SRT): 1-3 fractions, cumulative dose 1,300-1,800 cGy 4
- Combined with intraoperative platelet-rich plasma application 4
- Achieves 94% non-recurrence rate over 2 years 4
- Critical timing: Radiation must be administered postoperatively, as brachytherapy shows lowest recurrence rates (3.1-15%) among physical adjuvants 5
Conservative Management Options
For Smaller or Early Lesions
Intralesional Corticosteroids Alone:
- Triamcinolone acetonide 10 mg/mL for inflammatory lesions 1
- Triamcinolone acetonide 40 mg/mL for established keloids 1
- Recurrence rates: 6.6-33% depending on protocol 5
- Caution: Local overdose causes atrophy, pigmentary changes, and telangiectasias 1
Form-Pressure Therapy:
- After intrakeloid resection, apply pressure device at 24-30 mmHg 6
- Duration: approximately 25 weeks 6
- Particularly effective for maintaining pinna contours 6
- Compression therapy alone shows 10.66-14% recurrence rates for auricular keloids 5
Adjunctive Pharmacological Options
5-Fluorouracil:
- Can be combined with corticosteroids for refractory cases 5
- Reduces recurrence compared to surgery alone 5
Imiquimod 5%:
- Apply 5 times weekly for 1-3 months post-surgery 7
- Shows variable efficacy with higher recurrence rates than other adjuvants 5
- May be considered as supplementary therapy 8
Critical Pitfalls to Avoid
- Never perform surgery alone - Monotherapy has unacceptably high recurrence rates
- Avoid treating near eyes, nose, or lips with intralesional corticosteroids due to atrophy risk 1, 9
- Do not inject at sites of active infection (impetigo, herpes) 1
- Counsel patients with keloid history that any skin trauma carries uncertain outcomes 10
- Ensure proper injection technique - Overdosing causes permanent atrophy and pigmentary changes 1
Patient Selection Considerations
Contraindications for corticosteroid therapy:
- Active tuberculosis or systemic fungal infection
- Uncontrolled diabetes, heart failure, or severe hypertension
- Severe depression or psychosis
- Previous hypersensitivity to triamcinolone 1
Anatomical considerations:
- Helical rim keloids: Advancement flap technique preferred for lesions >2.5 cm 3
- Retroauricular or earlobe: Fillet flap procedure may be considered 7
- Location significantly impacts treatment selection and outcomes 5
Expected Outcomes
With optimal combined therapy (surgery + adjuvant treatment):
- Success rates: 94-96% 2, 4
- Mean follow-up demonstrating sustained results: 19-24 months 2, 4
- Patient satisfaction: 80% report good to excellent outcomes 7
Recurrence typically occurs when: